[Diamicron].
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D001786:Blood Glucose / Q000378:metabolism; D003517:Cyclopentanes / Q000494:pharmacology / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D011758:Pyrroles / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D013453:Sulfonylurea Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D014666:Vasomotor System / Q000187:drug effects
D001786:Blood Glucose; D003517:Cyclopentanes; D007004:Hypoglycemic Agents; D011758:Pyrroles; D013453:Sulfonylurea Compounds
Diamicron